West Pharmaceutical Services Inc (NYSE:WST)
| 303.64 BATS BZX Real-Time Price As of 1:32pm ET |  +1.26 / +0.42%Today’s Change | 275.89 Today|||52-Week Range 475.35 | -35.26% Year-to-Date |
Latest WST News | Press Releases
| West Pharmaceutical Services (WST) is a Top-Ranked Growth Stock: Should You Buy? Jun 24 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 302.37 |
| Today’s open | 302.84 |
| Day’s range | 299.96 - 305.01 |
| Volume | 131,278 |
| Average volume (3 months) | 428,472 |
| Market cap | $22.3B |
Data as of 1:32pm ET, 07/01/2022
Growth & Valuation
| Earnings growth (last year) | +89.88% |
| Earnings growth (this year) | +8.88% |
| Earnings growth (next 5 years) | +10.40% |
| Revenue growth (last year) | +31.86% |
| P/E ratio | 33.7 |
| Price/Sales | 12.64 |
| Price/Book | 9.57 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ZBHZimmer Biomet Holdin... | +0.46 | +0.44% |
| SAUHFStraumann Holding AG | +7.55 | +6.55% |
| DXCMDexcom Inc | +1.96 | +2.63% |
| PODDInsulet Corp | +4.39 | +2.01% |
Data as of 1:34pm ET, 07/01/2022
Financials
| Next reporting date | July 28, 2022 |
| EPS forecast (this quarter) | $2.22 |
| Annual revenue (last year) | $2.8B |
| Annual profit (last year) | $661.8M |
| Net profit margin | 23.38% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Exton, Pennsylvania |
Forecasts
